FN1 and atherosclerosis: EDA-FN occurrence in plasma at a high concentration is believed to be associated with inflammation and its release from tissues to the circulation during arterial wall lesions in thrombosis [39], plaque formation, development and progression of atherosclerosis, and arterial aging [24, 26–28].